**7. New antipseudomonal antibiotics**

Related to the emergence of multidrug-resistant strains, traditional antibiotic therapies against *P. aeruginosa* infections have become increasingly ineffective. The use of various antibiotic combinations and the development of new antibiotics are existing therapeutic options for *P. aeruginosa* treatment. New antibiotics have been shown to be more effective in destroying *P. aeruginosa* and have a lower frequency of production of resistance compared to current antibiotics due to their novel modes of action, efficient delivery of drugs (e.g. inhaled antibiotics) and resistance to bacterial enzyme alteration. Novel antibiotics with action against *P. aeruginosa* have been available in Europe in recent years and others are in advanced stages of clinical development. In certain instances, indirect evidence indicates their possible superiority over standard anti-pseudomonal regimes.
